Chinanews, December 10, according to a comprehensive report, according to real-time statistics from Johns Hopkins University in the United States, as of 7:28 on December 10, Beijing time, a total of more than 68.79 million confirmed cases of new crowns worldwide, and a total of deaths There are nearly 1.57 million cases.
In order to contain the epidemic, many countries have accelerated their new crown vaccination plans.
On December 7, local time, medical staff transported patients in a large hospital in Manhattan, New York.
Photo by China News Agency reporter Liao Pan
U.S. may approve emergency use of Pfizer vaccine
170,000 doses distributed in New York
At present, the United States is still the country with the worst new crown epidemic in the world, with a total of 15.35 million confirmed cases and a total of 288,000 deaths. It is urgent to curb the spread of the epidemic.
On the 9th local time, New York Governor Cuomo said that the state will receive the first batch of new crown vaccines as early as this weekend and will be provided to high-risk medical workers, nursing home residents and their staff first.
Cuomo said that the first shipment of 170,000 doses of Pfizer vaccine will be distributed according to the number of nursing home residents and health care workers in each region.
Among them, New York City, the most severely affected state in the state, will receive about 72,000 doses of vaccine.
Cuomo also said that, referring to federal guidelines, once the first batch of vaccinations are completed, the next goal of New York State is to vaccinate teachers, police and other front-line workers and people with a history of illness.
He said that ordinary people may not have the opportunity to be vaccinated until "early February" next year at the earliest.
On the other hand, the U.S. Food and Drug Administration (FDA) announced on the 8th that the United States did not raise new questions about the safety and effectiveness of Pfizer’s new crown vaccine, clearing up the emergency use authorization of this new crown pneumonia vaccine. obstacle.
It is expected that the FDA advisory committee will hold a meeting on the 10th local time to confirm whether to pass the emergency use authorization for Pfizer vaccine.
On December 8, local time, the United Kingdom began to receive the new crown vaccine.
Canada approves the first new crown vaccine
Two British doctors have allergic symptoms
On the 8th local time, the UK officially launched Pfizer's new crown vaccination work.
According to British media reports, two British health workers developed allergic symptoms after vaccination.
In view of this, the British drug regulatory agency recommends that people with a history of severe allergies do not receive Pfizer/BioNTech's new crown vaccine.
The British drug regulatory agency said it would seek further information and would prioritize investigating the matter. Pfizer and BioNTech said they are supporting the investigation.
Pfizer has previously stated that no people with a history of serious adverse allergic reactions to the vaccine or vaccine components participated in the later trials.
Adam Finn, professor of pediatric medicine at the University of Bristol, said: “Severe allergic reactions to vaccines are not common, but the staff responsible for vaccination have been trained and have the appropriate tools to deal with this situation.”
In addition to the United Kingdom, the Canadian health department also approved the use of the new crown vaccine on the 9th.
The Associated Press reported that the Canadian government has purchased 20 million doses of Pfizer vaccine and can choose to purchase an additional 56 million doses.
It is expected that in December, Canada will obtain up to 249,000 doses of vaccine, and 4 million doses will be obtained by March 2021.
At the same time, Health Canada is reviewing three other vaccine candidates, including the vaccine developed by Moderna in the United States.
On December 9, local time, in order to prevent the further spread of the new crown pneumonia epidemic, a library in Tokyo, Japan used ultraviolet light to disinfect the lent and returned books.
Japan and South Korea plan to introduce new crown vaccines from abroad
The time of mass vaccination has not yet been determined
The South Korean government recently stated that it will secure about 34 million doses of the new crown vaccine from four pharmaceutical companies including AstraZeneca, Janssen, Modena, and Pfizer.
It is predicted that the vaccine will enter South Korea in phases from February to March 2021, but the priority of which products to import and when to start vaccination have not yet been determined.
Pfizer Pharmaceuticals and the Japanese government have reached a basic agreement on the supply of 120 million doses of vaccines in the first half of 2021, but they will need to undergo clinical trials and review procedures in Japan. It is expected that vaccination will begin around March 2021 at the earliest.
In addition, the British pharmaceutical company AstraZeneca has also reached an agreement with Japan to provide 120 million doses of vaccines and is implementing clinical trials.
According to reports, the American biotechnology company Modena has also signed a contract with the Japanese government to provide 50 million doses of vaccines, but the clinical trials are still in the preparation stage.
Among Japanese domestic manufacturers, the pharmaceutical innovation company "AnGes" has also started clinical trials, and other companies such as Shiono Yoshino Pharmaceutical also plan to start trials in the near future.